| Illumina, Inc.. (9/21/20). "Press Release: Illumina to Acquire Grail to Launch New Era of Cancer Detection". San Diego, CA & Menlo Park, CA. |
2020-09-21 |
| Immune Regulation Ltd.. (9/21/20). "Press Release: Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing". London & Boston, MA. |
2020-09-21 |
| T-Knife GmbH. (9/21/20). "Press Release: T-Knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy". Berlin & Somerset, NJ. |
2020-09-21 |
| Compass Pathways plc. (9/18/20). "Press Release: Compass Pathways Announces Pricing of Upsized Initial Public Offering". London. |
2020-09-18 |
| Novo Holdings A/S. (9/17/20). "Press Release: Novo Ventures Co-leads US$83m Series C Financing in Lava Therapeutics". Copenhagen. |
2020-09-17 |
| InflaRx N.V.. (9/17/20). "Press Release: InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer". Jena. |
2020-09-17 |
| BioNTech SE. (9/17/20). "Press Release: BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021". Mainz. |
2020-09-17 |
| Boehringer Ingelheim. (9/17/20). "Press Release: Boehringer Ingelheim and Mirati Therapeutics Annonce Clinical Collaboration to Study BI 1701963, a SOS1::pan-KRAS Inhibitor in Combination with MRTX849, a KRAS G12C Selective Inhibitor". Ingelheim & San Di |
2020-09-17 |
| Qiagen N.V.. (9/17/20). "Press Release: Qiagen Fully Acquires NeuMoDx Molecular, Inc., Rounding Out Portfolio of PCR-based Diagnostic Automation Systems". Hilden & Ann Arbor, MI. |
2020-09-17 |
| Graphite Bio. (9/16/20). "Press Release: Graphite Bio Launches with $45 Million Series A Financing". South San Francisco, CA. |
2020-09-16 |
| Dinaqor AG. (9/16/20). "Press Release: Dinaqor AG Appoints Eduard Ayuso as Chief Technology Officer". Pfäffikon. |
2020-09-16 |
| Polyneuron Pharmaceuticals AG. (9/16/20). "Press Release: Polyneuron Extends Series A to CHF 36.5 Million with Additional CHF 14 Million". Basel. |
2020-09-16 |
| Moderna, Inc.. (9/16/20). "Press Release: Moderna Announces First Commercial Organization Outside North America in Switzerland". Cambridge, MA. |
2020-09-16 |
| Amadeus Capital Partners. (9/15/20). "Press Release: Amadeus Appoints New Partners Edward Kliphuis and Kai Schmitz". London & Bogotá. |
2020-09-15 |
| BioNTech SE. (9/15/20). "Press Release: BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". Mainz. |
2020-09-15 |
| ERS Genomics Ltd.. (9/14/20). "Press Release: ERS Genomics Provides Comment on US Patent Office Motions Decisions in CRISPR/Cas9 Interference Case". Dublin. |
2020-09-14 |
| Proteome Sciences plc. (9/14/20). "Press Release: Appointment of Chief Executive Officer". |
2020-09-14 |
| Neogene Therapeutics, Inc.. (9/14/20). "Press Release: Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies". New York, NY & Amsterdam. |
2020-09-14 |
| Boehringer Ingelheim. (9/11/20). "Press Release: Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia". Ingelheim & New |
2020-09-11 |
| Bruker Corporation. (9/11/20). "Press Release: Bruker Announces Acquisition of Canopy Biosciences, LLC". Billerica, MA. |
2020-09-11 |
| Gain Therapeutics, Inc.. (9/10/20). "Press Release: Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program". Bethesda, MD. |
2020-09-10 |
| Korro Bio, Inc.. (9/10/20). "Press Release: Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics". Cambridge, MA. |
2020-09-10 |
| Bayer AG. (9/10/20). "Press Release: Bayer – Supervisory Board Extends CEO Werner Baumann’s Contract until the End of April 2024. Company also Announces Progress in Roundup Settlements". Leverkusen. |
2020-09-10 |
| Bayer AG. (9/9/20). "Press Release: Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases". Berlin & Salt Lake City, UT. |
2020-09-09 |
| Evonetix Ltd.. (9/9/20). "Press Release: Evonetix and Analog Devices Collaborate onThird-Generation DNA Synthesis Platform". Cambridge. |
2020-09-09 |
| Recursion Pharmaceuticals, Inc.. (9/9/20). "Press Release: Recursion Secures $239 Million in Equity Financing to Advance Technology-Enabled Drug Discovery Platform and Pipeline". Salt Lake City, UT. |
2020-09-09 |
| Bayer Pharmaceuticals Corporation. (9/9/20). "Press Release: Bayer Completes Acquisition of the UK-based Biotech Company Kandy Therapeutics Ltd.". Whippany, NJ. |
2020-09-09 |
| Merck KGaA. (9/9/20). "Press Release: Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion". Darmstadt. |
2020-09-09 |
| Valneva S.E.. (9/8/20). "Press Release: Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553". Saint-Herblain. |
2020-09-08 |
| Metrion Biosciences Ltd.. (9/8/20). "Press Release: Metrion Biosciences Strengthens Global Business Development Team". Cambridge. |
2020-09-08 |
| Vibalogics GmbH. (9/8/20). "Press Release: Vibalogics Appoints Global CEO to Lead U.S. Expansion". |
2020-09-08 |
| C4 Therapeutics, Inc.. (9/8/20). "Press Release: Andrew Hirsch Named Chief Executive Officer of C4 Therapeutics". Watertown, MA. |
2020-09-08 |
| PhoreMost Ltd.. (9/8/20). "Press Release: PhoreMost and XtalPi Sign AI-based Pharmaceutical drug Discovery Collaboration Agreement". Cambridge & Cambridge, MA. |
2020-09-08 |
| Intravacc B.V.. (9/8/20). "Press Release: Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine". Bilthoven. |
2020-09-08 |
| Bruker Corporation. (9/8/20). "Press Release: Bruker Appoints Bonnie H. Anderson to its Board of Directors". Billerica, MA. |
2020-09-08 |
| Debiopharm International SA. (9/7/20). "Press Release: Belgian Scale-up Oncomfort Raises €10 million in Series A Funding Co-led by Debiopharm and Crédit Mutuel Innovation". Brussels, Lausanne & Paris. |
2020-09-07 |
| IcanoMab GmbH. (9/7/20). "Press Release: IcanoMab GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in Oncology, Immune-Modulation, Acute Inflammation and Most Urgently for Covid-19". Polling. |
2020-09-07 |
| Grifols S.A.. (9/7/20). "Press Release: Grifols to Acquire Alkahest to Enhance Discovery Research and Development". Barcelona & San Carlos, CA. |
2020-09-07 |
| EuropaBio. (9/3/20). "Press Release: Novartis’s Andrew Topen Appointed as New Chairman of EuropaBio". |
2020-09-03 |
| BrickBio. (9/2/20). "Press Release: BrickBio Validates Its Novel Therapeutic Conjugation Platform at Commercial Scale". Boston, MA. |
2020-09-02 |
| Merck KGaA. (9/2/20). "Press Release: Merck Places Hybrid Bond Amounting to €1.0 billion". Darmstadt. |
2020-09-02 |
| BrickBio Inc.. (9/2/20). "Press Release: Therapeutic Conjugation Advancement – BrickBio Expands Space to Accommodate Pharma Partnerships and Pipeline Development". Boston, MA. |
2020-09-02 |
| BiomX Inc.. (9/2/20). "Press Release: BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease". Ness Ziona. |
2020-09-02 |
| Oculis S.A.. (9/1/20). "Press Release: Oculis Establishes Presence in U.S. and Appoints Sylvia Cheung as Chief Financial Officer". Lausanne. |
2020-09-01 |
| Aimmune Therapeutics, Inc.. (8/31/20). "Press Release: Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science". Brisbane, CA. |
2020-08-31 |
| Entasis Therapeutics Inc.. (8/28/20). "Press Release: Entasis Therapeutics Announces $25 Million Private Placement". Waltham, MA. |
2020-08-28 |
| Cellink AB. (8/28/20). "Press Release: Cellink Welcomes New Scientific Advisor Professor Ido Amit from the Weizmann Institute of Science". Gothenburg. |
2020-08-28 |
| Bayer AG. (8/27/20). "Press Release: Bayer and Northpond Ventures Lead USD 55 Million Series A Financing Round for Triumvira Immunologics". Leverkusen & Austin, TX. |
2020-08-27 |
| Agilent Technologies Inc.. (8/27/20). "Press Release: Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model". Santa Clara, CA. |
2020-08-27 |
| Royal Philips. (8/27/20). "Press Release: Philips to Expand Its Image-guided Therapy Devices Portfolio through Acquisition of Intact Vascular". Amsterdam. |
2020-08-27 |
| Foundation Medicine, Inc.. (8/26/20). "Press Release: FDA Approves Foundation Medicine's FoundationOne Liquid CDx, a Comprehensive Pan-Tumor Liquid Biopsy Test with Multiple Companion Diagnostic Indications for Patients with Advanced Cancer". Cambridge, |
2020-08-26 |
| Immunovia AB. (8/26/20). "Press Release: Immunovia Announces CEO Transition. Appoints Patrik Dahlen as New CEO". Lund. |
2020-08-26 |
| Freenome, Inc.. (8/26/20). "Press Release: Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection". South San Francisco, CA. |
2020-08-26 |
| NewAmsterdam Pharma B.V.. (8/25/20). "Press Release: NewAmsterdam Pharma Acquires Obicetrapib from Amgen". Naarden. |
2020-08-25 |
| Calliditas Therapeutics AB. (8/25/20). "Press Release: Calliditas Appoints Group General Counsel". |
2020-08-25 |
| Engitix Ltd.. (8/25/20). "Press Release: Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases". London. |
2020-08-25 |
| Bruker Corporation. (8/24/20). "Press Release: Bruker and Purity-IQ Sign Partnership Agreement to Transform the Cannabis Regulatory Landscape". Billerica, MA. |
2020-08-24 |
| Moderna, Inc.. (8/24/20). "Press Release: Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)". Cambridge, MA. |
2020-08-24 |
| IN8bio, Inc.. (8/24/20). "Press Release: Incysus Therapeutics Announces Name Change to IN8bio, Inc.". New York, NY. |
2020-08-24 |
| Bayer AG. (8/24/20). "Press Release: Bayer and Informed Data Systems Inc. (One Drop) Join Forces to Jointly Develop Digital Health Products across Therapeutic Areas". Berlin. |
2020-08-24 |
| Qiagen N.V.. (8/21/20). "Press Release: Qiagen Announces New Chairman of Supervisory Board". Venlo. |
2020-08-21 |
| Kymera Therapeutics Inc.. (8/20/20). "Press Release: Kymera Therapeutics Announces Pricing of Upsized Initial Public Offering". Watertown, MA. |
2020-08-20 |
| Scienion AG. (8/19/20). "Press Release: Cellink Has Entered into an Agreement to Acquire Precision Dispensing Company Scienion AG". |
2020-08-19 |
| Galapagos N.V.. (8/19/20). "Press Release: Galapagos Announces that Gilead Received a Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis". Mechelen. |
2020-08-19 |
| MLM Medical Labs GmbH. (8/19/20). "Press Release: MLM Medical Labs Appoints Isabel Struik as VP Sales & Marketing". Düsseldorf. |
2020-08-19 |
| Qiagen N.V.. (8/18/20). "Press Release: Qiagen Expands Integrated Coronavirus NGS and Software Solutions to Accelerate COVID-19 Research". Hilden & Germantown, MD. |
2020-08-18 |
| Bayer AG. (8/18/20). "Press Release: Bayer Names Sara Boettiger as Head of Global Public Affairs, Science and Sustainability for Crop Science Division". Monheim. |
2020-08-18 |
| CureVac B.V.. (8/18/20). "Press Release: CureVac Announces Closing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-18 |
| Sanofi S.A.. (8/17/20). "Press Release: Sanofi to Acquire Principia Biopharma". Paris & South San Francisco, CA. |
2020-08-17 |
| Merck KGaA. (8/17/20). "Press Release: Merck Appoints Liz Henderson as New Regional Vice President, Merck Biopharma APAC". Singapore. |
2020-08-17 |
| Mobilion Systems, Inc.. (8/17/20). "Press Release: Mobilion Closes $35M Series B Financing Round". Chadds Ford, PA. |
2020-08-17 |
| CureVac B.V.. (8/14/20). "Press Release: CureVac Announces Pricing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-14 |
| Qiagen N.V.. (8/13/20). "Press Release: Qiagen to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation after Voluntary Public Takeover Offer Falls Short". Venlo. |
2020-08-13 |
| Novo Holdings A/S. (8/12/20). "Press Release: Novo Ventures Portfolio Company F2G Closes US$60.8 Million Financing". Copenhagen. |
2020-08-12 |
| Galapagos N.V.. (8/12/20). "Press Release: Scipher Medicine and Galapagos Sign Collaboration in Inflammatory Bowel Disease". Mechelen & Boston, MA. |
2020-08-12 |
| Atomwise, Inc.. (8/11/20). "Press Release: Atomwise Raises $123 Million in Series B Financing Co-Led by B Capital Group and Sanabil". San Francisco, CA. |
2020-08-11 |
| Bluebird Bio, Inc.. (8/11/20). "Press Release: Bluebird Bio Appoints Denice Torres to Board of Directors". Cambridge, MA. |
2020-08-11 |
| Saillant Therapeutics B.V.. (8/11/20). "Press Release: Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication". Nijmegen. |
2020-08-11 |
| Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin. |
2020-08-11 |
| Immunic, Inc.. (8/10/20). "Press Release: Immunic, Inc. Announces Closing of $103.5 Million Public Offering, including Full Exercise of Underwriters’ Option to Purchase Additional Shares". New York, NY. |
2020-08-10 |
| Dyne Therapeutics Inc.. (8/10/20). "Press Release: Dyne Therapeutics Announces $115 Million Financing to Advance Pipeline of Modern Oligonucleotide Therapeutics for Serious Muscle Diseases". Waltham, MA. |
2020-08-10 |
| CureVac B.V.. (8/10/20). "Press Release: CureVac Announces Proposed Initial Public Offering of Common Shares". Tübingen. |
2020-08-10 |
| Ligand Pharmaceuticals Inc.. (8/10/20). "Press Release: Ligand to Acquire Pfenex Inc.". San Diego, CA. |
2020-08-10 |
| Ligand Pharmaceuticals Inc.. (8/7/20). "Press Release: CStone Announces That OmniAb-derived CS1001 (Anti-PD-L1) Phase 3 Trial Met the Primary Endpoint as First-Line Treatment in Stage IV Squamous and Non-squamous NSCLC". San Diego, CA. |
2020-08-07 |
| Pacific Biosciences of California, Inc.. (8/7/20). "Press Release: Pacific Biosciences Announces New Chief Executive Officer. Christian O. Henry Named Chief Executive Officer". Menlo Park, CA. |
2020-08-07 |
| Nura Bio Inc.. (8/7/20). "Press Release: Structural and Mechanistic Regulation of SARM1’s Transition from Autoinhibited to Neurotoxic State Published in CELL REPORTS". South San Francisco, CA. |
2020-08-07 |
| T-Knife GmbH. (8/6/20). "Press Release: T-Knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies". Berlin. |
2020-08-06 |
| Merck KGaA. (8/6/20). "Press Release: Leadership Change within Group Communications at Merck". Darmstadt. |
2020-08-06 |
| Immunic, Inc.. (8/5/20). "Press Release: Immunic, Inc. Announces Pricing of $90.0 Million Public Offering of Common Stock". New York, NY. |
2020-08-05 |
| Affimed N.V.. (8/5/20). "Press Release: Affimed Announces Two New Appointments to Its Supervisory Board". Heidelberg. |
2020-08-05 |
| Versant Ventures. (8/5/20). "Press Release: Versant Ventures Launches Matterhorn Biosciences". Basel. |
2020-08-05 |
| AC Immune S.A.. (8/5/20). "Press Release: AC Immune Reports Q2 2020 Financial Results and Provides Business Update". Lausanne. |
2020-08-05 |
| Taysha Gene Therapies. (8/5/20). "Press Release: Taysha Gene Therapies Announces Oversubscribed $95 Million Series B Financing". Dallas, TX. |
2020-08-05 |
| Spindiag GmbH. (8/4/20). "Press Release: Spindiag Appoints Winston Griffin as Chief Financial Officer to Support its Global Finance and Market Expansion Strategy". Freiburg/Breisgau. |
2020-08-04 |
| Twist Bioscience Corporation. (8/4/20). "Press Release: Seismic Bio Partners With Twist Bioscience for Discovery and Optimization of Antibodies". South San Francisco, CA. |
2020-08-04 |
| Thermo Fisher Scientific Inc.. (8/4/20). "Press Release: Thermo Fisher Scientific Confirms Offer to Acquire Qiagen Shares Expires on August 10". Waltham, MA. |
2020-08-04 |
| CureVac AG. (8/4/20). "Press Release: CureVac Appoints Dr. Franz-Werner Haas as Chief Executive Officer and Dr. Igor Splawski as Chief Scientific Officer". Tübingen. |
2020-08-04 |
| Dyne Therapeutics Inc.. (8/3/20). "Press Release: Dyne Therapeutics Appoints Susanna High as Chief Operating Officer". Waltham, MA. |
2020-08-03 |
| NBE Therapeutics AG. (8/3/20). "Press Release: NBE-Therapeutics Appoints Bertrand Damour as Chief Executive Officer". Basel. |
2020-08-03 |
| Siemens Healthineers AG. (8/2/20). "Press Release: Siemens Healthineers Plans Acquisition of Varian". |
2020-08-02 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo-2019.png){kind=logo}
Date![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
